DEF 14AThe Ballot
REGENERON PHARMACEUTICALS, INC. files DEF 14A
Filed Apr 26, 2019 · 7y ago · Accession 0000930413-19-001350
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- REGN
- CIK
- 872589
- Form type
- DEF 14A
- Filing date
- Apr 26, 2019
- Report date
- Jun 14, 2019
- Document
- c92333_def14a.htm
- Size
- 7.1 MB